Non‐Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline
Pain Practice · 2025-11 · 25 (8)
DOI: 10.1111/papr.70084 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pain Practice, online erschienen am 24.10.2025. Verfasst von Peter J Goadsby und 4 weiteren Autor:innen. Beteiligte Einrichtung: NIHR King's Clinical Research Facility and Wolfson SPARC, King's College London, London, UK. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Cluster Headache. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cluster headache (CH) is a rare but severe primary headache disorder characterized by recurrent attacks of unilateral, typically periocular pain lasting 15 min to 3 h, accompanied by ipsilateral autonomic symptoms and restlessness or agitation. Attacks may occur multiple times daily and present in clusters lasting weeks to months, interspersed with remission periods in episodic CH, or without remission in chronic CH.
Methods
This review summarizes the clinical evidence supporting the use of transcutaneous cervical vagus nerve stimulation (tcVNS) for both the acute and preventive treatment of CH. Relevant clinical trials, real‐world studies, and guideline recommendations are discussed.
Results
Pharmacological therapy for CH includes triptans and high‐flow oxygen for acute management, and verapamil, corticosteroids, or galcanezumab for prevention. For patients with inadequate response or intolerance to these options, neuromodulation may be required. TcVNS has emerged as a noninvasive, safe, and effective alternative to invasive neuromodulation. Clinical trials have demonstrated significant reductions in attack frequency and intensity, leading to U.S. Food and Drug Administration (FDA) clearance and UK National Institute for Health and Care Excellence (NICE) approval for both acute and preventive treatment of CH.
Conclusions
TcVNS represents a well‐tolerated, noninvasive neuromodulatory option for patients with cluster headache, offering both acute and preventive benefits. This paper provides an overview of the current evidence, mechanisms of action, and practical guidelines for incorporating tcVNS into clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NIHR King's Clinical Research Facility and Wolfson SPARC, King's College London, London, UK.
- Department of Neurology, University of California, Los Angeles, California, USA.
- Synergy Integrative Headache Center, Chicago, Illinois, USA.
- American Interventional Headache Society, Bath, Ohio, USA.
- Neurology Department of Clinical Sciences, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.
- Department of Anesthesia and Critical Care Medicine, University of Chicago Medicine, Chicago, Illinois, USA.
ORCID-Profile: Peter Staats
Zitieren
APA
Goadsby, P. J., Feoktistov, A., Anitescu, M., Day, M., & Staats, P. (2025). Non‐Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline. Pain Practice, 25(8). https://doi.org/10.1111/papr.70084
Vancouver
Goadsby PJ, Feoktistov A, Anitescu M, Day M, Staats P. Non‐Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline. Pain Practice. 2025;25(8). doi:10.1111/papr.70084
BibTeX
@article{Goadsby2025,
author = {Goadsby, Peter J and Feoktistov, Alexander and Anitescu, Magdalena and Day, Miles and Staats, Peter},
title = {Non‐Invasive Vagus Nerve Stimulation in Cluster Headache: A Clinical Practice Guideline},
journal = {Pain Practice},
year = {2025},
volume = {25},
number = {8},
doi = {10.1111/papr.70084}
}
EUVIMED